Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. latamerica
  4. brain damage
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

Brain Damage Articles & Analysis

32 news found

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Synaptive Medical to Test New Software for Brain Surgery Planning at Unity Health Toronto

Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. ...

BySynaptive Medical


Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus

Intermountain Primary Children’s Hospital First in Nation to Successfully Implant New Brain Shunt Accessory for Patients with Hydrocephalus

Surgeons at Intermountain Primary Children’s Hospital are the first in the nation to successfully implant a new brain shunt accessory for young patients with hydrocephalus, a neurological condition that causes a buildup of cerebrospinal fluid in the deep cavities of the brain that often causes frequent hospitalizations. This extra fluid puts pressure on ...

ByAnuncia Medical, Inc.


Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Anuncia Medical Announces the First Successful US Implant of the Company’s Newly Commercially Released ReFlow Mini Flusher Device for Hydrocephalus Patients

Performed by neurosurgeon Samuel Cheshier, MD, at Intermountain Primary Children’s Hospital in Salt Lake City, the patient previously required at least 11 brain surgeries to manage their hydrocephalus, a chronic neurological condition in which excess CSF accumulates in the brain, often causing severe symptoms, frequent hospitalizations, and ongoing health ...

ByAnuncia Medical, Inc.


Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

Bayer progressing well with transformation of pharma business and raises peak sales potential of key growth drivers to over twelve billion euros

Its most advanced program BRT-DA01 is being developed for the treatment of Parkinson’s disease, a progressive neurodegenerative disorder caused by nerve cell damage in the brain. It comprises of pluripotent stem cell-derived dopaminergic neurons that are implanted into the brain, thus taking target at the root cause of the disease. ...

ByBayer AG


gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Neurobehavioral Outcomes in a Model of Traumatic Brain Injury

(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced data from an oral presentation at Neurocritical Care Society’s (NCS) 20th Annual Meeting held in San Antonio, Texas on October 17 – 21, 2022 on the possible role of gammaCore (nVNS) in the acute treatment of Traumatic Brain Injury (TBI). The presentation is being given by Dr. Afshin ...

ByelectroCore, Inc.


Lumosa One of the Finalists for Clinical Advance of the Year Award in Scrip Awards 2022

Lumosa One of the Finalists for Clinical Advance of the Year Award in Scrip Awards 2022

The drug improves stroke treatment rates while expanding treatment coverage, providing neuroprotection, and reducing irreversible damage to the brain ...

ByLumosa Therapeutics Co., Ltd.


Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss

Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss

” Auditory neuropathy is a hearing disorder in which the inner ear successfully detects sound but has a problem with sending signals from the ear to the brain. Current state of the art medical knowledge suggests that auditory neuropathies play a substantial role in hearing impairments and deafness. ...

ByLineage Cell Therapeutics, Inc.


Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF)

Optina, an innovative diagnostics company, leader in retinal imaging, brain health and systemic disease detection, announces the closing of an up to US$2.1M investment from the Alzheimer’s Drug Discovery Foundation (ADDF). ...

ByOptina Diagnostics


BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

Andres Lozano, O.C., M.D., Ph.D., F.R.C.S.C., F.R.S.C., F.C.A.H.S., Principal Investigator at the Krembil Brain Institute, University Health Network states, “with this surgery, our objective is to use authentic cells, to have them integrate into the brain and restore lost physiologic function. ...

ByBlueRock Therapeutics


BlueRock Therapeutics Announces Closeout of First Cohort in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

BlueRock Therapeutics Announces Closeout of First Cohort in Phase 1 Trial in Patients with Advanced Parkinson’s Disease

About Parkinson’s Disease Parkinson’s disease is a progressive neurodegenerative disorder caused by nerve cell damage in the brain, leading to decreased dopamine levels. The worsening of motor and non-motor symptoms is caused by the loss of dopamine-producing neurons. ...

ByBlueRock Therapeutics


Breakthrough Israeli stroke therapy technology BrainQ announces a $40M funding round

Breakthrough Israeli stroke therapy technology BrainQ announces a $40M funding round

In the days and weeks following stroke, the brain attempts to repair damaged neural pathways and develop new ones to restore function, but often with limited success. ...

ByBrainQ Technologies


WVXU: Local Company’s Brain Scanner Can Quickly Detect Damage, Which Could Help The Military And Beyond

WVXU: Local Company’s Brain Scanner Can Quickly Detect Damage, Which Could Help The Military And Beyond

More than 400,000 military personnel have suffered at least one traumatic brain injury in the last two decades. Long-term consequences for patients may have been better if doctors could more quickly have diagnosed the situation and treated it. Now there appears to be a solution and it involves the Norwood company Sense Neuro Diagnostics. ...

BySense Neuro Diagnostics


BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson`s Disease

BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson`s Disease

About Parkinson’s Disease Parkinson’s disease is a progressive neurodegenerative disorder caused by nerve cell damage in the brain, leading to decreased dopamine levels. The worsening of motor and non-motor symptoms is caused by the loss of dopamine-producing neurons. ...

ByBlueRock Therapeutics


BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson`s Disease

BlueRock Therapeutics Announces First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson`s Disease

“It’s both exciting and humbling to be a part of delivering this first-of-its-kind medicine to Parkinson’s patients, with the hope of re-innervating the human brain to make profound and lasting improvements to the quality of life for PD patients,” said Emile Nuwaysir, Ph.D., President and Chief Executive Officer of BlueRock. “Our objective is to use ...

ByBlueRock Therapeutics


BlueRock Therapeutics Receives Permission from Health Canada for DA01 Trial in Parkinson’s Disease

BlueRock Therapeutics Receives Permission from Health Canada for DA01 Trial in Parkinson’s Disease

About Parkinson’s Disease Parkinson’s disease is a progressive neurodegenerative disorder caused by nerve cell damage in the brain, leading to decreased dopamine levels. The worsening of motor and non-motor symptoms is caused by the loss of dopamine-producing neurons. ...

ByBlueRock Therapeutics


BrainQ gets FDA Breakthrough status for its device for reducing disability following stroke

BrainQ gets FDA Breakthrough status for its device for reducing disability following stroke

In the days and weeks following stroke, the brain attempts to repair damaged neural pathways and develop new ones to restore function, but often with limited success. ...

ByBrainQ Technologies


BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson`s Disease

BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson`s Disease

It is an important milestone on the road towards regenerative brain repair,” said Viviane Tabar, MD, founding investigator of BlueRock and Chair of MSK’s Department of Neurosurgery. ...

ByBlueRock Therapeutics


1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that

1 out of 10 survive cardiac arrest, a new device under FDA review hopes to change that

The Neurescue device is designed to increase blood flow to the brain and heart during life-threatening emergencies such as cardiac arrest. ...

ByNeurescue


Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics

Optina Diagnostics and Wagner Macula Retina Center will Collaborate to Conduct a Clinical Study and Develop a Unique in-community Patient access Program Aimed to Identify the Causes of Memory Loss through Eye Diagnostics

It brings together a whole new paradigm for the way we think about, how we diagnose and how we understand brain health and Alzheimer’s. This is the first market readiness collaboration where Optina will deploy its exclusive eye clinic program & Retinal Deep Phenotyping platform in a community setting. It will prepare the ground for additional prime eye clinics locations ...

ByOptina Diagnostics


How Does Snoring Affect Your Brain?

How Does Snoring Affect Your Brain?

In addition to the health issues and fatigue that are associated with snoring, it is now known that frequent snoring can actually cause harm to the brain. The most recent research on brain health and snoring shows the damage that can occur, and further emphasizes why it is crucial to stop chronic snoring as soon as possible. ...

ByTannerMedico A/S - Asonor

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT